atherosclerosis l-carnitine Trimethylamine - an overview Dietary allicin reduces transformation of
Dietary allicin reduces transformation of L carnitine to TMAO through impact on gut microbiota ScienceDirect The Carnitine butyrobetaine trimethylamine N oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis Atherosclerosis Butyrobetaine is a pro atherogenic intermediate in gut microbial metabolism of L carnitine to TMAO PMC Intestinal microbiota metabolism of L carnitine, a nutrient in red meat, promotes atherosclerosis PMC Evolving targets for the treatment of atherosclerosis ScienceDirect
Pay in 4 interest-free payments of $6.57 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15




